Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Depreciation and Depletion: 2016-2018

Historic Depreciation and Depletion for Arrowhead Pharmaceuticals (ARWR) over the last 3 years, with Sep 2018 value amounting to $3.0 million.

  • Arrowhead Pharmaceuticals' Depreciation and Depletion fell 23.00% to $578,342 in Q2 2019 from the same period last year, while for Jun 2019 it was $2.9 million, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2018, which is 0.30% up from last year.
  • Latest data reveals that Arrowhead Pharmaceuticals reported Depreciation and Depletion of $3.0 million as of FY2018, which was up 0.30% from $3.0 million recorded in FY2017.
  • Arrowhead Pharmaceuticals' Depreciation and Depletion's 5-year high stood at $3.0 million during FY2018, with a 5-year trough of $1.5 million in FY2016.
  • Its 3-year average for Depreciation and Depletion is $2.5 million, with a median of $3.0 million in 2017.
  • Data for Arrowhead Pharmaceuticals' Depreciation and Depletion shows a peak YoY skyrocketed of 93.44% (in 2017) over the last 5 years.
  • Over the past 3 years, Arrowhead Pharmaceuticals' Depreciation and Depletion (Yearly) stood at $1.5 million in 2016, then spiked by 93.44% to $3.0 million in 2017, then increased by 0.30% to $3.0 million in 2018.